Pneumothorax, Barotrauma, Emphysema
Pneumothorax, Barotrauma, Emphysema is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 10k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the occurrence, diagnosis, and management of spontaneous pneumomediastinum, particularly in the context of COVID-19. It covers related complications such as pneumothorax, subcutaneous emphysema, and barotrauma, as well as the Macklin effect. The papers also discuss the impact of COVID-19 on the incidence and clinical characteristics of pneumomediastinum.
- COVID-19
- Pneumomediastinum
- Spontaneous
- Barotrauma
- Pneumothorax
- Emphysema
- Macklin Effect
- Diagnosis
- Management
- Review
- Research works
- 10k fractional, since 1950
- In the world top 10%
- 1k per year above
- Top-10% rate
- 10.2% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +2% the tick is no change
- Largest producer
United States
36% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Pneumothorax, Barotrauma, Emphysema research?
By volume, the United States and Japan publish the most (538 and 167 works in 2022-now).
By volume, 2022-now
- 1
United States
538 works
- 2
Japan
167 works
- 3
India
166 works
- 4
China
164 works
- 5
United Kingdom
104 works
- 6
Türkiye
94 works
- 7
Italy
90 works
- 8
Spain
69 works
- 9
Germany
67 works
- 10
Brazil
50 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pneumothorax, Barotrauma, Emphysema research?
By volume in 2022-now, All India Institute of Medical Sciences publishes the most Pneumothorax, Barotrauma, Emphysema research, followed by Mayo Clinic and Sichuan University.
By volume, 2022-now
- 1
All India Institute of Medical SciencesIndia
18 works
- 2
Mayo ClinicUnited States
11 works
- 3
Sichuan UniversityChina
10 works
- 4
Harvard UniversityUnited States
10 works
- 5
Sağlık Bilimleri ÜniversitesiTürkiye
10 works
- 6
New York Medical CollegeUnited States
9 works
- 7
Mexican Social Security Institute
Mexico
8 works
- 8
University of California, Los AngelesUnited States
7 works
- 9
Cleveland ClinicUnited States
7 works
- 10
Northwell HealthUnited States
7 works
Who are the leading researchers in Pneumothorax, Barotrauma, Emphysema?
The most-cited researchers publishing on Pneumothorax, Barotrauma, Emphysema include Jean‐Louis Vincent, Jasvinder A. Singh and Didier Raoult.
- 1
Jean‐Louis Vincent
Belgium
262k citations
- 2
Jasvinder A. Singh
United States
247k citations
- 3
Didier Raoult
France
232k citations
- 4
Ziad Ahmed Memish
Saudi Arabia
224k citations
- 5
Andrew S. Levey
United States
197k citations
- 6
Rinaldo Bellomo
Australia
182k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pneumothorax, Barotrauma, Emphysema research done?
The largest centres of Pneumothorax, Barotrauma, Emphysema research in 2022-now are Tokyo (Japan), Istanbul (Türkiye), London (United Kingdom) and New Delhi (India).
Where is the best place to study Pneumothorax, Barotrauma, Emphysema?
Among universities, judged by research, Harvard University, All India Institute of Medical Sciences and Sichuan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States |
54.9 | 24.3% | 1.6× | 10 | -39.7% |
| 2 | All India Institute of Medical SciencesIndia |
44.7 | 7.4% | 8.4× | 18 | -11.4% |
| 3 | Sichuan UniversityChina |
44.7 | 14.9% | 2.3× | 10 | +204.8% |
| 4 | New York Medical CollegeUnited States |
21.1 | 8.6% | 20.3× | 9 | -9.9% |
| 5 | Sağlık Bilimleri ÜniversitesiTürkiye |
19.9 | 4.5% | 8.9× | 10 | -19.4% |
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Pneumothorax, Barotrauma, Emphysema, country by countryIs Pneumothorax, Barotrauma, Emphysema research growing?
Output in 2022-2025 was 2% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Pneumothorax, Barotrauma, Emphysema.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Pneumothorax, Barotrauma, Emphysema as a percentage of every work published that year, 0.0080% in 2024.
Fractional works of Pneumothorax, Barotrauma, Emphysema over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Pneumothorax, Barotrauma, Emphysema. Posts are plain text and can be reported.